Sumitomo Dainippon Pharma Co Financial Overview
Sumitomo Dainippon Pharma Co's market cap is currently ¥925.30B. The company's EPS TTM is ¥220.63; its P/E ratio is 6.04; Sumitomo Dainippon Pharma Co is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is ¥-0.87. See an overview of income statement, balance sheet, and cash flow financials.
